Clerkenwell Health raises funding to open psychedelic clinical research facility in London — TFN

Clerkenwell Health, a British clinical research startup, has secured over £700,000 in pre-seed funding from investors like Vine Ventures and Lionheart Ventures. They are opening Europe's first commercial facility for psychedelic-assisted therapies in London this summer, aiming to conduct trials on conditions like PTSD and addiction. Their initial trials with Psyence will focus on using psilocybin to treat adjustment disorder in terminally ill patients.

Clerkenwell Health Raises £700K to Open Psychedelic Research Facility in London

Clerkenwell Health is a British specialist clinical research startup focused on psychedelic-assisted therapies. They are conducting research on various mental health conditions like mood disorders, trauma-related conditions, and addictions. They are also exploring conditions not previously targeted with psychedelic therapies. The company has just opened Europe's first commercial facility dedicated to psychedelic-assisted therapies in London, aiming to begin trials in August.

A UK-based specialist clinical research startup focusing on psychedelic-assisted therapies.

3 years ago

Clerkenwell Health Raises £700K to Open Psychedelic Research Facility in London

Covered on